Fact CheckerSign in

NCT07196267Completed

Shockwave and Cryoflow for Shoulder Pain After Stroke

Combination Effect of Extracorporeal Shockwave and Cryoflow Therapy on Rotator Cuff Tendonitis in Stroke Patients

Source: ClinicalTrials.gov · Last updated 5 Jan 2026

Brief summary (registry, in English)

This study aims to find out whether combining two physical therapy treatments - Extracorporeal Shockwave Therapy and Cryoflow Therapy - can help reduce shoulder pain and improve function in patients who have developed rotator cuff tendonitis after a stroke. Participants will be divided into groups to receive either one therapy alone or both therapies together. Researchers will measure pain levels, shoulder movement, and daily function before and after treatment to see which approach works best. The goal is to find a more effective, non-drug way to manage shoulder pain in stroke survivors and help them regain better use of their arm.

Status (registry)
Completed
Study type
Interventional
Enrollment
30 (actual)
First submitted
19 Sept 2025
Start date
10 Oct 2025
Primary completion date
30 Oct 2025
Lead sponsor
MTI University
Diseases
Stroke
NCT number
NCT07196267

What you commit to

  • Study type: Interventional
  • Participants enrolled: 30
  • From 10 Oct 2025 to the primary completion date, 30 Oct 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • History of shoulder surgery or fracture. Presence of shoulder subluxation or dislocation. Severe cognitive impairment or inability to communicate. Uncontrolled hypertension, cardiac disease, or other unstable medical conditions.
    • Skin lesions, open wounds, or infection over the shoulder region. Diagnosis of frozen shoulder (adhesive capsulitis), rheumatoid arthritis, or other inflammatory joint diseases.
    • Previous treatment with ESWT or cryotherapy for shoulder within the last 6 months.
    • Use of botulinum toxin injections in the upper limb within the last 3 months

Who the study is looking for

  • Diagnosis of stroke confirmed by neurologist via physical examination and MRI. Age between 50 and 70 years. Moderate to severe shoulder spasticity, graded as Stage 3 on the Modified Ashworth Scale (MAS) for shoulder adductors.
    • Medically stable (vital signs within normal limits). Conscious, cooperative, and able to follow instructions. No orthopedic conditions, surgeries, or injuries affecting the shoulder or upper limb.
    • No sensory impairments (visual, auditory, proprioceptive) that would interfere with assessment or treatment.
    • Able to provide informed consent.

Age in the registry: 50 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Faculty of Physical Therapy, Benha University
Coordinator of this site? Confirm its status
CairoEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.